490 related articles for article (PubMed ID: 27368089)
21. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
Alyami H; Dahmash E; Bowen J; Mohammed AR
PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
[TBL] [Abstract][Full Text] [Related]
22. Enabling the Tablet Product Development of 5-Fluorocytosine by Conjugate Acid Base Cocrystals.
Perumalla SR; Paul S; Sun CC
J Pharm Sci; 2016 Jun; 105(6):1960-1966. PubMed ID: 27238493
[TBL] [Abstract][Full Text] [Related]
23. Microcrystalline cellulose from soybean hull as an excipient in solid dosage forms: Preparation, powder characterization, and tableting properties.
Alamdari NE; Aksoy B; Babu RJ; Jiang Z
Int J Biol Macromol; 2024 Jun; 270(Pt 1):132298. PubMed ID: 38750863
[TBL] [Abstract][Full Text] [Related]
24. Crystal and Particle Engineering Strategies for Improving Powder Compression and Flow Properties to Enable Continuous Tablet Manufacturing by Direct Compression.
Chattoraj S; Sun CC
J Pharm Sci; 2018 Apr; 107(4):968-974. PubMed ID: 29247737
[TBL] [Abstract][Full Text] [Related]
25. Improved tabletability after a polymorphic transition of delta-mannitol during twin screw granulation.
Vanhoorne V; Bekaert B; Peeters E; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2016 Jun; 506(1-2):13-24. PubMed ID: 27094358
[TBL] [Abstract][Full Text] [Related]
26. Investigation of the potential for direct compaction of a fine ibuprofen powder dry-coated with magnesium stearate.
Qu L; Zhou QT; Gengenbach T; Denman JA; Stewart PJ; Hapgood KP; Gamlen M; Morton DA
Drug Dev Ind Pharm; 2015 May; 41(5):825-37. PubMed ID: 24738790
[TBL] [Abstract][Full Text] [Related]
27. Dry coating of micronized API powders for improved dissolution of directly compacted tablets with high drug loading.
Han X; Ghoroi C; Davé R
Int J Pharm; 2013 Feb; 442(1-2):74-85. PubMed ID: 22921376
[TBL] [Abstract][Full Text] [Related]
28. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
[TBL] [Abstract][Full Text] [Related]
29. Modulation of the powder properties of lamotrigine by crystal forms.
Kavanagh ON; Wang C; Walker GM; Sun CC
Int J Pharm; 2021 Feb; 595():120274. PubMed ID: 33486026
[TBL] [Abstract][Full Text] [Related]
30. Faster to First-time-in-Human: Prediction of the liquid solid ratio for continuous wet granulation.
Junnila A; Wikström H; Megarry A; Gholami A; Papathanasiou F; Blomberg A; Ketolainen J; Tajarobi P
Eur J Pharm Sci; 2022 May; 172():106151. PubMed ID: 35217210
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the Effect of Microcrystalline Cellulose Variations on Tablet Quality of Natural Plant Product Using a Design of Experiment Approach.
Zhao H; Shi C; Liu Z; Zhao L; Shen L
AAPS PharmSciTech; 2023 May; 24(5):113. PubMed ID: 37127722
[TBL] [Abstract][Full Text] [Related]
32. Development of Coprocessed Chitin-Calcium Carbonate as Multifunctional Tablet Excipient for Direct Compression, Part 2: Tableting Properties.
Chaheen M; Bataille B; Yassine A; Belamie E; Sharkawi T
J Pharm Sci; 2019 Oct; 108(10):3319-3328. PubMed ID: 31145923
[TBL] [Abstract][Full Text] [Related]
33. Modeling of quantitative relationships between physicochemical properties of active pharmaceutical ingredients and tensile strength of tablets using a boosted tree.
Hayashi Y; Oishi T; Shirotori K; Marumo Y; Kosugi A; Kumada S; Hirai D; Takayama K; Onuki Y
Drug Dev Ind Pharm; 2018 Jul; 44(7):1090-1098. PubMed ID: 29376430
[TBL] [Abstract][Full Text] [Related]
34. Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating.
Huang Z; Scicolone JV; Han X; Davé RN
Int J Pharm; 2015 Jan; 478(2):447-55. PubMed ID: 25475016
[TBL] [Abstract][Full Text] [Related]
35. Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods.
Chen H; Wang C; Kang H; Zhi B; Haynes CL; Aburub A; Sun CC
Int J Pharm; 2020 Jan; 574():118914. PubMed ID: 31811924
[TBL] [Abstract][Full Text] [Related]
36. Material-Sparing and Expedited Development of a Tablet Formulation of Carbamazepine Glutaric Acid Cocrystal- a QbD Approach.
Yamashita H; Sun CC
Pharm Res; 2020 Jul; 37(8):153. PubMed ID: 32705421
[TBL] [Abstract][Full Text] [Related]
37. Cinnamyl O-amine functionalized chitosan as a new excipient in direct compressed tablets with improved drug delivery.
Ren G; Clancy C; Tamer TM; Schaller B; Walker GM; Collins MN
Int J Biol Macromol; 2019 Dec; 141():936-946. PubMed ID: 31487516
[TBL] [Abstract][Full Text] [Related]
38. Provoking an end-to-end continuous direct compression line with raw materials prone to segregation.
Lakio S; Ervasti T; Tajarobi P; Wikström H; Fransson M; Karttunen AP; Ketolainen J; Folestad S; Abrahmsén-Alami S; Korhonen O
Eur J Pharm Sci; 2017 Nov; 109():514-524. PubMed ID: 28899763
[TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of surface-engineered coarse microcrystalline cellulose through dry coating with silica nanoparticles.
Zhou Q; Shi L; Chattoraj S; Sun CC
J Pharm Sci; 2012 Nov; 101(11):4258-66. PubMed ID: 22927169
[TBL] [Abstract][Full Text] [Related]
40. Surface engineered excipients: I. improved functional properties of fine grade microcrystalline cellulose.
Chen L; Ding X; He Z; Huang Z; Kunnath KT; Zheng K; Davé RN
Int J Pharm; 2018 Jan; 536(1):127-137. PubMed ID: 29191481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
